INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 430m ago
HOUSE PTR29m ago
SEC 13F29m ago
ROBINHOOD CHAIN29m ago
SEC FORM 4/Disposition to issuerVerified data

Alves Sandra Isabelle Barros reported RPTX

SVP, Finance and CAO · Repare Therapeutics Inc. · Common Shares

Side
D
Value
—
Shares
31.6K
Price
—
Executed
Jan 28, 2026
Disclosed
Jan 28, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Jan 28 executedJan 28, 2026 disclosed

RPTX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Disposition to issuer — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 0 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · RPTX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    AB
    Alves Sandra Isabelle BarrosSVP, Finance and CAO
    RPTXRepare Therapeutics Inc.
    Disposition to issuer
    		D—
    26.0K sh
    		Jan 28, 2026Jan 28, 2026
    traded Jan 28, 2026
    		+0dSEC FORM 4

    Evidence

    9
    AB
    Alves Sandra Isabelle BarrosSVP, Finance and CAO
    RPTXRepare Therapeutics Inc.
    Disposition to issuer
    		D—
    24.5K sh
    		Jan 28, 2026Jan 28, 2026
    traded Jan 28, 2026
    		+0dSEC FORM 4

    Evidence

    9
    FS
    Forte SteveEVP, CHIEF FINANCIAL OFFICER
    RPTXRepare Therapeutics Inc.
    Disposition to issuer
    		D—
    200.0K sh
    		Jan 28, 2026Jan 28, 2026
    traded Jan 28, 2026
    		+0dSEC FORM 4

    Evidence

    9
    FS
    Forte SteveEVP, CHIEF FINANCIAL OFFICER
    RPTXRepare Therapeutics Inc.
    Disposition to issuer
    		D—
    85.0K sh
    		Jan 28, 2026Jan 28, 2026
    traded Jan 28, 2026
    		+0dSEC FORM 4

    Evidence

    9
    FS
    Forte SteveEVP, CHIEF FINANCIAL OFFICER
    RPTXRepare Therapeutics Inc.
    Disposition to issuer
    		D—
    500.0K sh
    		Jan 28, 2026Jan 28, 2026
    traded Jan 28, 2026
    		+0dSEC FORM 4

    Evidence

    9
    FS
    Forte SteveEVP, CHIEF FINANCIAL OFFICER
    RPTXRepare Therapeutics Inc.
    Disposition to issuer
    		D—
    325.8K sh
    		Jan 28, 2026Jan 28, 2026
    traded Jan 28, 2026
    		+0dSEC FORM 4

    Evidence

    9
    CT
    Civik ThomasDirector
    RPTXRepare Therapeutics Inc.
    Disposition to issuer
    		D—
    7,500 sh
    		Jan 28, 2026Jan 28, 2026
    traded Jan 28, 2026
    		+0dSEC FORM 4

    Evidence

    9
    FS
    Forte SteveEVP, CHIEF FINANCIAL OFFICER
    RPTXRepare Therapeutics Inc.
    Disposition to issuer
    		D—
    56.8K sh
    		Jan 28, 2026Jan 28, 2026
    traded Jan 28, 2026
    		+0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002065621-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 28, 2026
    Published
    Jan 28, 2026
    Ingested by INSIDER
    Nov 5, 04:20 UTC
    Last re-read
    Nov 5, 04:20 UTC

    Extracted facts

    Filer
    Alves Sandra Isabelle Barros
    Role
    SVP, Finance and CAO
    Transaction
    Disposition to issuerAs filed: “D”
    Asset
    Repare Therapeutics Inc.
    Ticker
    RPTX
    Shares
    31.6K
    Execution date (reported)
    Jan 28, 2026
    Owned after transaction
    0 shares
    Days from execution to publication
    0

    What this establishes

    Alves Sandra Isabelle Barros filed this Form 4 reporting a disposition to issuer of RPTX on Jan 28, 2026. It became public on Jan 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    SVP, Finance and CAO
    Alves Sandra Isabelle Barroscik:0002065621
    Issuer
    Repare Therapeutics Inc.cik:0001808158

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.

    Source error

    Price history for RPTX is unavailable.

    An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.